Alenson Carman 4
4 · Prime Medicine, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Alenson Carman
See Remarks
Transactions
- Award
Stock Option (right to buy)
[F1]2026-02-23+140,000→ 140,000 totalExercise: $3.34Exp: 2036-02-23→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 23, 2026, subject to the Reporting Person's continued service on each such vesting date.
Signature
/s/ Ryan Brown, attorney-in-fact|2026-02-24